RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: sex cord-gonadal stromal tumor
Accession: DOID:192
browse the term
Definition: A reproductive organ cancer that is located_in the sex cord-derived tissues of the ovary or testis and derives_from granulosa cells, Leydig cells, Sertoli cells, and fibroblasts. (DO)
Synonyms: exact_synonym: gynandroblastoma; gynandroblastomas; sex cord stromal tumour; sex cord-gonadal stromal tumour; sex cord-stromal neoplasm; sex cord-stromal tumor; sex cord-stromal tumors; specialized gonadal neoplasm; specialized gonadal tumor; specialized gonadal tumour
narrow_synonym: malignant testicular sex cord-stromal tumor; malignant testicular sex cord-stromal tumour
xref: EFO:1000052 ; ICDO:8590/1; MESH:D018312 ; MONDO:0006055 ; NCI:C3794
For additional species annotation, visit the
Alliance of Genome Resources .
G
GNAS
GNAS complex locus
IAGP
ClinVar Annotator: match by term: Sex cord-stromal tumor
ClinVar
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
G
INHA
inhibin subunit alpha
susceptibility
ISO
RGD
PMID:8090730
RGD:2301690
NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
G
AMH
anti-Mullerian hormone
disease_progression
IEP
RGD
PMID:19359032
RGD:2315639
NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
G
BMP4
bone morphogenetic protein 4
ISO
mRNA:increased expression:ovary
RGD
PMID:16488995
RGD:1643593
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
CCND2
cyclin D2
IEP
mRNA:increased expression:ovary
RGD
PMID:11994539
RGD:2289157
NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
G
CDKN2A
cyclin dependent kinase inhibitor 2A
IEP
RGD
PMID:12203782
RGD:2296066
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CDKN2B
cyclin dependent kinase inhibitor 2B
IEP
RGD
PMID:12203782
RGD:2296066
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CMKLR1
chemerin chemokine-like receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29653259
NCBI chr12:108,288,046...108,339,311
Ensembl chr12:108,288,044...108,339,317
G
CTNNB1
catenin beta 1
ISO ISS
MouseDO RGD
PMID:16488995
RGD:1643593
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
FANCF
FA complementation group F
disease_progression susceptibility
IDA ISO
DNA:hypermethylation:promoter
RGD
PMID:15574200 PMID:21915857
RGD:2298508 , RGD:11049141
NCBI chr11:22,622,533...22,625,823
Ensembl chr11:22,622,533...22,625,823
G
FHIT
fragile histidine triad diadenosine triphosphatase
IDA
DNA:hypermethylation:promoter, ovary
RGD
PMID:15574200
RGD:2298508
NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
G
FSHR
follicle stimulating hormone receptor
IEP
mRNA:increased expression:tumor:significantly higher vs epithelial tumors or normal ovary (p<0.01)
RGD
PMID:11994539
RGD:2289157
NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
G
GNAI2
G protein subunit alpha i2
IAGP
ClinVar Annotator: match by term: Granulosa cell tumor, somatic
ClinVar
PMID:2116665
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
IEP
mRNA:decreased expression:ovary
RGD
PMID:18028988
RGD:2302173
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
LEPR
leptin receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28861689
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
ISO IEP
mRNA:decreased expression:tumor:significantly lower vs normal ovary (p<0.05)
RGD
PMID:15967102 PMID:11994539
RGD:2302176 , RGD:2289157
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
MGMT
O-6-methylguanine-DNA methyltransferase
IAGP
DNA:hypermethylation:promoter (human)
RGD
PMID:14970867
RGD:2317693
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
PRKAR2B
protein kinase cAMP-dependent type II regulatory subunit beta
IEP
mRNA:increased expression:tumor:significantly higher vs epithelial tumors or normal ovary (p<0.01)
RGD
PMID:11994539
RGD:2289157
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
G
PTGS2
prostaglandin-endoperoxide synthase 2
IEP
mRNA:increased expression:tumor:significantly higher vs epithelial tumors or normal ovary (p<0.01)
RGD
PMID:11994539
RGD:2289157
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RARRES2
retinoic acid receptor responder 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29653259
NCBI chr 7:150,338,329...150,341,629
Ensembl chr 7:150,338,317...150,341,662
G
SGK1
serum/glucocorticoid regulated kinase 1
IEP
mRNA:decreased expression:tumor:significantly lower vs normal ovary (p<0.01)
RGD
PMID:11994539
RGD:2289157
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
G
SMAD1
SMAD family member 1
ISO
RGD
PMID:17967875
RGD:2299978
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
G
SMAD5
SMAD family member 5
ISO
RGD
PMID:17967875
RGD:2299978
NCBI chr 5:136,132,845...136,182,733
Ensembl chr 5:136,132,845...136,188,747
G
ST14
ST14 transmembrane serine protease matriptase
IEP
protein:increased expression:ovary
RGD
PMID:16439987
RGD:2315091
NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362
G
VEGFA
vascular endothelial growth factor A
IMP
RGD
PMID:19524286
RGD:2315463
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
WIF1
WNT inhibitory factor 1
ISO
mRNA:increased expression:ovary
RGD
PMID:16488995
RGD:1643593
NCBI chr12:65,050,626...65,121,305
Ensembl chr12:65,050,626...65,121,305
G
GNAI2
G protein subunit alpha i2
IAGP
ClinVar Annotator: match by term: Granulosa cell tumor of the ovary
ClinVar
PMID:2116665
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
CDK4
cyclin dependent kinase 4
ISO
associated with Multiple Endocrine Neoplasia Type 1;protein:increased expression:testes
RGD
PMID:18310289
RGD:2293582
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
associated with Multiple Endocrine Neoplasia Type 1;protein:decreased activity:testes
RGD
PMID:18310289
RGD:2293582
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CGA
glycoprotein hormones, alpha polypeptide
IEP
RGD
PMID:16007123
RGD:2293633
NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106
G
ESR1
estrogen receptor 1
IEP
protein:increased expression:testis
RGD
PMID:17656605
RGD:2290041
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
FLT1
fms related receptor tyrosine kinase 1
IEP
RGD
PMID:14517422
RGD:2301251
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
INHA
inhibin subunit alpha
ISO
RGD
PMID:11545298
RGD:2290379
NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
G
LHB
luteinizing hormone subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25289773
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
ISO EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:transversion:CDS:1732G>C, amino acid D578H
CTD RGD
PMID:10580072 PMID:11857565 PMID:15967102 PMID:11857565
RGD:2302176 , RGD:2292537
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
PDGFA
platelet derived growth factor subunit A
IEP
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDGFB
platelet derived growth factor subunit B
IEP
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFRA
platelet derived growth factor receptor alpha
IEP
mRNA:alternative form:testis protein:increased expression:testis, leydig cell
RGD
PMID:11920744 PMID:11994382
RGD:2298580 , RGD:2298579
NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
G
PDGFRB
platelet derived growth factor receptor beta
IEP
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872
G
PRL
prolactin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:4092719
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PRMT5
protein arginine methyltransferase 5
IEP
protein:altered localization
RGD
PMID:17437848
RGD:2299953
NCBI chr14:22,920,529...22,929,376
Ensembl chr14:22,920,525...22,929,408
G
INHA
inhibin subunit alpha
ISO
RGD
PMID:10602485
RGD:2290369
NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
G
INHA
inhibin subunit alpha
IEP
protein:increased expression:tumor:focal expression in Sertoli cells, stronger diffuse expression in Leydig cells
RGD
PMID:17414107
RGD:2290367
NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
IAGP
ClinVar Annotator: match by term: Leydig cell adenoma, somatic, with male-limited precocious puberty
ClinVar
PMID:10580072 PMID:11857565
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
STON1-GTF2A1L
STON1-GTF2A1L readthrough
IAGP
ClinVar Annotator: match by term: Leydig cell adenoma, somatic, with male-limited precocious puberty
ClinVar
PMID:10580072 PMID:11857565
NCBI chr 2:48,529,925...48,776,519
Ensembl chr 2:48,529,925...48,776,517
G
GNAI2
G protein subunit alpha i2
IAGP
ClinVar Annotator: match by term: Thecoma, somatic
ClinVar
PMID:2116665
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all